Jubilant Ingrevia to invest ₹600 crore annually for expansion
pre-market1 source ↓written by the desknot a recommendation
- to expand production
- ₹500-600 crore annually
- investment
- ₹2,000 crore
- in revenue
- 20-25% annual growth
Jubilant Ingrevia plans to invest ₹500-600 crore annually to expand production of Vitamin B3 and B4. This follows a ₹2,000 crore investment over the past three years. The firm aims for 20-25% annual growth in revenue and EBITDA by FY27, enhancing operations at Bharuch and Gajraula.
Not investment advice. For informational purposes only.